These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23506041)

  • 1. Intravenous topiramate: comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers.
    Clark AM; Kriel RL; Leppik IE; Marino SE; Mishra U; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1099-105. PubMed ID: 23506041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetic analysis of USL255, a new once-daily extended-release formulation of topiramate.
    Lambrecht LJ; Shekh-Ahmad T; Todd WM; Halvorsen MB; Bialer M
    Epilepsia; 2011 Oct; 52(10):1877-83. PubMed ID: 21770925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation.
    Bialer M; Shekh-Ahmad T; Braun TL; Halvorsen MB
    Epilepsia; 2013 Aug; 54(8):1444-52. PubMed ID: 23692553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase.
    Shank RP; Doose DR; Streeter AJ; Bialer M
    Epilepsy Res; 2005 Feb; 63(2-3):103-12. PubMed ID: 15715969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects.
    Nunes T; Sicard E; Almeida L; Falcão A; Rocha JF; Brunet JS; Lefebvre M; Soares-da-Silva P
    Curr Med Res Opin; 2010 Jun; 26(6):1355-62. PubMed ID: 20377319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic modelling of intravenous and oral topiramate and its effect on phonemic fluency in adult healthy volunteers.
    Ahmed GF; Marino SE; Brundage RC; Pakhomov SV; Leppik IE; Cloyd JC; Clark A; Birnbaum AK
    Br J Clin Pharmacol; 2015 May; 79(5):820-30. PubMed ID: 25403343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers.
    Piñeyro-López A; Piñeyro-Garza E; Gómez-Silva M; Reyes-Araiza R; Flores-Diego MA; Borrego-Alvarado S; Gamino-Peña ME; Vargas-Zapata R; Salazar-Leal ME
    Clin Ther; 2009 Feb; 31(2):411-7. PubMed ID: 19302913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasma pharmacokinetics and cerebral spinal fluid penetration of intravenous topiramate in newborn pigs.
    Galinkin JL; Kurth CD; Shi H; Priestley MA; Loepke AW; Adamson PC
    Biopharm Drug Dispos; 2004 Sep; 25(6):265-71. PubMed ID: 15334626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the absence and in the presence of enzyme induction by carbamazepine.
    Britzi M; Perucca E; Soback S; Levy RH; Fattore C; Crema F; Gatti G; Doose DR; Maryanoff BE; Bialer M
    Epilepsia; 2005 Mar; 46(3):378-84. PubMed ID: 15730535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
    Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
    Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate and lamotrigine pharmacokinetics during repetitive monotherapy and combination therapy in epilepsy patients.
    Doose DR; Brodie MJ; Wilson EA; Chadwick D; Oxbury J; Berry DJ; Schwabe S; Bialer M
    Epilepsia; 2003 Jul; 44(7):917-22. PubMed ID: 12823574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
    Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
    Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers.
    Meador KJ; Loring DW; Vahle VJ; Ray PG; Werz MA; Fessler AJ; Ogrocki P; Schoenberg MR; Miller JM; Kustra RP
    Neurology; 2005 Jun; 64(12):2108-14. PubMed ID: 15985582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncated AUCs in the assessment of the bioequivalence of topiramate, a long half-life drug.
    Almeida S; Spínola AC; Filipe A; Trabelsi F; Farré A
    Arzneimittelforschung; 2007; 57(5):249-53. PubMed ID: 17598694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers.
    Agarwal SK; Kriel RL; Brundage RC; Ivaturi VD; Cloyd JC
    Epilepsy Res; 2013 Aug; 105(3):362-7. PubMed ID: 23561287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy.
    Rosenfeld WE; Liao S; Kramer LD; Anderson G; Palmer M; Levy RH; Nayak RK
    Epilepsia; 1997 Mar; 38(3):324-33. PubMed ID: 9070595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
    Ramael S; Daoust A; Otoul C; Toublanc N; Troenaru M; Lu ZS; Stockis A
    Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.